Effects of hypoxia on the alveolar epthelium

缺氧对肺泡上皮的影响

基本信息

  • 批准号:
    7435394
  • 负责人:
  • 金额:
    $ 39.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-01 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

Patients with acute lung injury develop hypoxemia and gas exchange impairment which results in significant morbidity and mortality. It has been reported that hypoxia may impair the lung's ability to clear edema by inhibiting Na+ channels and the Na,K-ATPase in the alveolar epithelium. The focus of this application is to determine whether severe hypoxia of 1.5% or 3% (about 10 or 20 mm Hg) for 1 to 4 hours inhibits Na,K-ATPase by causing endocytosis of the Na+ pump into intracellular compartments via specific pathways activated by reactive oxygen species (ROS) and protein kinase C (PKC) signaling molecules. We will determine whether after exposure to hypoxia, reoxygenation of the alveolar epithelial cells (AEC) results in the recruitment of previously endocytosed Na+ pumps back into the cell basolateral membranes (BLM). We will study whether activation of the protein kinase A pathway by terbutaline and forskolin reverses the effects of hypoxia on AEC Na+ pumps and whether this increases lung liquid clearance. We will also determine whether in AEC exposed to prolonged hypoxia (>12 hours) the Na,K-ATPase proteins undergo ubiquitination and degradation via the proteasomal or lysosomal pathways. As such, we will study the effects of hypoxia on the alveolar epithelium by focusing on the mechanisms of Na,K-ATPase regulation in four interrelated aims: in Specific Aim # 1 we propose to determine the role of mitochondrial ROS generated during hypoxia on Na,K-ATPase function and protein endocytosis; in Specific Aim # 2 we will study whether the alveolar epithelial Na,K-ATPase is phosphorylated during hypoxia by PKC triggering the endocytosis of the Na+ pump; in Specific Aim # 3 we will determine whether hypoxia-mediated inhibition of the Na,K-ATPase function and endocytosis of the Na+ pump are reversible upon reoxygenation and whether activation of the PKA pathway by terbutaline and forskolin prevents or reverses the effects of hypoxia; in Specific Aim # 4 we propose to determine whether prolonged exposure of AEC to hypoxia leads to ubiquitination and degradation of the Na,K-ATPase proteins via the proteosomal/lysosomal pathways. Experiments have been conducted for each of the specific aims and the preliminary results support the feasibility of this proposal. Completion of the proposed studies will provide novel information on the effects of hypoxia on the alveolar epithelium, specifically as it pertains to mechanisms of inhibition and degradation of the Na+ pump as well as pathways of reversal of Na,K-ATPase inhibition, which may be of importance for the design of novel approaches to increase edema clearance in patients with pulmonary edema.
急性肺损伤患者出现低氧血症和气体交换障碍,导致严重的发病率和死亡率。据报道,低氧可能通过抑制肺泡上皮细胞中的Na+通道和Na,K-ATPase而损害肺清除水肿的能力。这一应用的重点是确定1.5%或3%(约10或20 mm Hg)的严重缺氧1-4小时是否通过由活性氧(ROS)和蛋白激酶C(PKC)信号分子激活的特定途径引起Na+泵内吞到细胞内而抑制Na,K-ATPase。我们将确定在暴露于低氧后,肺泡上皮细胞(AEC)的复氧是否导致先前内吞的Na+泵重新回到细胞基侧膜(BLM)。我们将研究特布他林和Forsklin激活蛋白激酶A通路是否能逆转低氧对AEC Na+泵的影响,以及这是否会增加肺液清除。我们还将确定在长时间缺氧(>12小时)的AEC中,Na,K-ATPase 蛋白质通过蛋白酶体或溶酶体途径进行泛素化和降解。因此,我们将从四个相互关联的目的来研究低氧对肺泡上皮细胞Na,K-ATPase调节机制的影响:在特定目的#1中,我们建议确定低氧时产生的线粒体ROS对Na,K-ATPase功能和蛋白质内吞作用的作用;在特定目的#2中,我们将研究在低氧条件下,肺泡上皮细胞Na,K-ATPase是否通过PKC触发Na+泵的内吞而被磷酸化;在特定的目标#3中,我们将确定缺氧对Na,K-ATPase功能和Na+泵的内吞的抑制是否在复氧时是可逆的,以及特布他林和Forsklin激活PKA通路是否可以阻止或逆转缺氧的影响;在特定的目标#4中,我们建议确定AEC长期暴露在低氧中是否通过蛋白酶体/溶酶体途径导致Na,K-ATPase蛋白的泛素化和降解。针对每个具体目标进行了实验,初步结果支持了该方案的可行性。这些研究的完成将为低氧对肺泡上皮细胞的影响提供新的信息,特别是与Na+泵的抑制和降解机制以及Na,K-ATPase抑制的逆转途径有关的信息,这可能对设计新的方法来增加肺水肿患者的水肿清除具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jacob I Sznajder其他文献

RETRACTED ARTICLE: Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ
撤回文章:Miz1 通过抑制 C/EBP-δ 抑制炎症和急性肺损伤
  • DOI:
    10.1038/ni.2566
  • 发表时间:
    2013-03-24
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Hanh Chi Do-Umehara;Cong Chen;Daniela Urich;Liang Zhou;Ju Qiu;Samuel Jang;Alia Zander;Margaret A Baker;Martin Eilers;Peter H S Sporn;Karen M Ridge;Jacob I Sznajder;G R Scott Budinger;Gökhan M Mutlu;Anning Lin;Jing Liu
  • 通讯作者:
    Jing Liu

Jacob I Sznajder的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jacob I Sznajder', 18)}}的其他基金

Role of hypercapnia on the lung airways
高碳酸血症对肺气道的作用
  • 批准号:
    9903435
  • 财政年份:
    2019
  • 资助金额:
    $ 39.92万
  • 项目类别:
Role of hypercapnia on the lung airways
高碳酸血症对肺气道的作用
  • 批准号:
    10115793
  • 财政年份:
    2019
  • 资助金额:
    $ 39.92万
  • 项目类别:
Role of hypercapnia on the lung airways
高碳酸血症对肺气道的作用
  • 批准号:
    10369052
  • 财政年份:
    2019
  • 资助金额:
    $ 39.92万
  • 项目类别:
Pathophysiology of Alveolar Epithelial Lung Injury
肺泡上皮性肺损伤的病理生理学
  • 批准号:
    7824799
  • 财政年份:
    2009
  • 资助金额:
    $ 39.92万
  • 项目类别:
The injurious effects of hypercapnia on the alveolar epithelium
高碳酸血症对肺泡上皮的损伤作用
  • 批准号:
    7824414
  • 财政年份:
    2009
  • 资助金额:
    $ 39.92万
  • 项目类别:
Recruitment of New Faculty to Enhance Research in Lung Biology
招聘新教师以加强肺生物学研究
  • 批准号:
    7936173
  • 财政年份:
    2009
  • 资助金额:
    $ 39.92万
  • 项目类别:
Recruitment of New Faculty to Enhance Research in Lung Biology
招聘新教师以加强肺生物学研究
  • 批准号:
    7858936
  • 财政年份:
    2009
  • 资助金额:
    $ 39.92万
  • 项目类别:
The injurious effects of hypercapnia on the alveolar epithelium
高碳酸血症对肺泡上皮的损伤作用
  • 批准号:
    7256236
  • 财政年份:
    2006
  • 资助金额:
    $ 39.92万
  • 项目类别:
The injurious effects of hypercapnia on the alveolar epithelium
高碳酸血症对肺泡上皮的损伤作用
  • 批准号:
    8384840
  • 财政年份:
    2006
  • 资助金额:
    $ 39.92万
  • 项目类别:
The injurious effects of hypercapnia on the alveolar epithelium
高碳酸血症对肺泡上皮的损伤作用
  • 批准号:
    8584306
  • 财政年份:
    2006
  • 资助金额:
    $ 39.92万
  • 项目类别:

相似海外基金

CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6564818
  • 财政年份:
    2001
  • 资助金额:
    $ 39.92万
  • 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
  • 批准号:
    6410976
  • 财政年份:
    2000
  • 资助金额:
    $ 39.92万
  • 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
  • 批准号:
    6370267
  • 财政年份:
    2000
  • 资助金额:
    $ 39.92万
  • 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6418789
  • 财政年份:
    2000
  • 资助金额:
    $ 39.92万
  • 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
  • 批准号:
    6370266
  • 财政年份:
    2000
  • 资助金额:
    $ 39.92万
  • 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
  • 批准号:
    6370265
  • 财政年份:
    2000
  • 资助金额:
    $ 39.92万
  • 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6302122
  • 财政年份:
    1999
  • 资助金额:
    $ 39.92万
  • 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
  • 批准号:
    6309780
  • 财政年份:
    1999
  • 资助金额:
    $ 39.92万
  • 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6109540
  • 财政年份:
    1998
  • 资助金额:
    $ 39.92万
  • 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
  • 批准号:
    6265845
  • 财政年份:
    1998
  • 资助金额:
    $ 39.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了